24.4 C
Vientiane
Thursday, April 3, 2025
spot_img

Laotian Times

Fireworks & Drone Shows Light Up Haikou’s Lantern Festival

HAIKOU, China, Feb. 13, 2025 /PRNewswire/ -- A report from Hainan International Media Center: On Feb. 12, the date of the 2025 Lantern...

SM C2R (Singapore) and Advanced Lighting Company (ALC) Strengthen Strategic Partnership Through Joint Ownership of SM C2R Arabia to Support Saudi Vision 2030

SINGAPORE and RIYADH, Saudi Arabia, Feb. 13, 2025 /PRNewswire/ -- SM C2R (Singapore), a member of Swan & Maclaren Group, and Advanced Lighting Company...

enreap Earns 2025 Great Place To Work Certification™

PUNE, India, Feb. 13, 2025 /PRNewswire/ -- enreap is proud to be Certified™ by Great Place To Work® for the third year in a row....

WEL Networks Selects IFS’s AIP platform Copperleaf to Enhance Asset Investment Planning

VANCOUVER, BC, Feb. 13, 2025 /PRNewswire/ -- IFS, the leading provider of enterprise cloud and Industrial AI software, announces that WEL Networks, a leading...

‘Tianjin Port Impression’ experience hall opens: A fusion of culture, tourism and commerce

BEIJING, Feb. 13, 2025 /PRNewswire/ -- A news report from China Daily: Visitors in the immersive...

OneConnect Integrates DeepSeek into AI Agent Platform

SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- OneConnect Financial Technology Co., Ltd ("OneConnect" or the "Company", NYSE: OCFT, HKSE: 6638), a business technology service provider...

Namibox, Tencent, and Sichuan Education Press Forge Strategic Partnership to Develop Innovative AI-Powered Learning Solutions

SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- Jinxin Technology Holding Company (the "Company") (Nasdaq: NAMI), an innovative provider of digital-content products and services in China,...

Conrad Xiamen Awarded Four-Star Recognition in the 2025 Forbes Travel Guide

The Only Forbes-Starred Hotel in Xiamen XIAMEN, China, Feb. 13, 2025 /PRNewswire/ -- Conrad Xiamen proudly announces its Four-Star recognition in the 2025 Forbes...

Accropeutics Announces First Patient Dosed in Phase Ib Study of RIPK2 Inhibitor AC-101

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms...